Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders

European Journal of Clinical Pharmacology

Volumn 68, Issue 12, 2012, Pages 1647-1655

  Conti, Valentino ^a   Lora, Antonio ^b   Cipriani, Andrea ^c   Fortino, Ida ^d   Merlino, Luca ^d   Barbui, Corrado ^c  

^a Regional Centre for Pharmacovigilance   (Italy)

^b Azienda Ospedaliera della Provincia di Lecco   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Operative Unit of Territorial Health Services   (Italy)

Author keywords

Antidepressants; Antipsychotics; Mood stabilizers; Persistence; Severe mental disorders

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; DISEASE SEVERITY; DIVORCE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; INTENSIVE CARE; ITALY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MEDICAL SPECIALIST; MENTAL DISEASE; MENTAL HEALTH CARE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TREATMENT DURATION;

ADULT; FEMALE; HUMANS; ITALY; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS; MIDDLE AGED; PSYCHIATRY; SPECIALIZATION;

EID: 84871261623     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-012-1298-2     Document Type: Article

References (43)

1. Ascher-Svanum H, Faries DE, Zhu B et al (2006) Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care. J Clin Psychiatry 67:453-460
2. Gjerden P, Slordal L, Bramness JG (2010) Prescription persistence and safety of antipsychotic medication: a national registry-based 3- year follow-up. Eur J Clin Pharmacol 66:911-917
3. Hassan M, Madhavan SS, Kalsekar ID et al (2007) Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder. Ann Pharmacother 41:1812-1818
4. Vlahiotis A, Devine ST, Eichholz J et al (2011) Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans. J Manag Care Pharm 17:123-132
5. Ascher-Svanum H, Zhu B, Faries DE et al (2008) Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia. Patient Prefer Adherence 2:67-77
6. Ascher-Svanum H, Zhu B, Faries D et al (2006) A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry 67:1114- 1123
7. Ascher-Svanum H, Zhu B, Faries D et al (2006) Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia. BMC Psychiatry 6:8
8. Brnabic AJ, Kelin K, Ascher-Svanum H, et al. (2011)Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12- month observational study. Int J Clin Pract 65:945-953
9. Cooper D, Moisan J, Gregoire JP (2007) Adherence to atypical antipsychotic treatment among newly treated patients: a populationbased study in schizophrenia. J Clin Psychiatry 68:818-825
10. Kelin K, Lambert T Jr, Brnabic AJ et al (2011) Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Prefer Adherence 5:213-222
11. Kreyenbuhl J, Slade EP, Medoff DR et al (2011) Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia. Schizophr Res 131:127-132
12. Lang K, Meyers JL, Korn JR et al (2010) Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr Serv 61:1239-1247
13. Zhu B, Ascher-Svanum H, Shi L et al (2008) Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia. Psychiatr Serv 59:315-317
14. Rascati KL, Richards KM, Ott CA et al (2011) Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder. Psychiatr Serv 62:1032-1040
15. Lu CY, Roughead E (2011) New users of antidepressant medications: first episode duration and predictors of discontinuation. Eur J Clin Pharmacol 68:65-71
16. Milea D, Guelfucci F, Bent-Ennakhil N et al (2010) Antidepressant monotherapy: a claims database analysis of treatment changes and treatment duration. Clin Ther 32:2057-2072
17. Milea D, Verpillat P, Guelfucci F et al (2010) Prescription patterns of antidepressants: findings from a US claims database. Curr Med Res Opin 26:1343-1353
18. Sanglier T, Saragoussi D, Milea D et al (2011) Comparing antidepressant treatment patterns in older and younger adults: a claims database analysis. J Am Geriatr Soc 59:1197-1205
19. Sytema S, Micciolo R, Tansella M (1997) Continuity of care for patients with schizophrenia and related disorders: a comparative South-Verona and Groningen case-register study. Psychol Med 27:1355-1362
20. Tansella M, Amaddeo F, Burti L et al (2006) Evaluating a community-based mental health service focusing on severe mental illness. The Verona experience. Acta Psychiatr Scand 113 (Suppl s429):90-94
21. Lora A (2009) An overview of the mental health system in Italy. Ann Ist Super Sanita 45:5-16
22. Tansella M, De SD, Williams P (1987) The Italian psychiatric reform: some quantitative evidence. Soc Psychiatry 22:37-48
23. Lora A, Conti V, Leoni O et al (2011) Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in lombardy, Italy. Psychiatr Serv 62:1079-1084
24. Tansella M, Micciolo R, Biggeri A et al (1995) Episodes of care for first-ever psychiatric patients. A long-term case-register evaluation in a mainly urban area. Br J Psychiatry 167:220-227
25. Percudani M, Belloni G, Contini A et al (2002) Monitoring community psychiatric services in Italy: differences between patients who leave care and those who stay in treatment. Br J Psychiatry 180:254-259
26. National Collaborating Centre for Mental Health (2010) Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care (updated edition). National Institute for Clinical Excellence, London
27. National Collaborating Centre for Mental Health (2010) Depression. The treatment and management of depression in adults (updated edition). National Institute for Clinical Excellence, London
28. National Collaborating Centre for Mental Health (2006) The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Institute for Clinical Excellence, London
29. Lora A, Barbato A, Cerati G et al (2011) The mental health system in Lombardy, Italy: access to services and patterns of care. Soc Psychiatry Psychiatr Epidemiol 7(3):447-454
30. WHO (1992) Manual of the international classification of diseases, injuries, and causes of death, 10th ed. World Health Organization, Geneva
31. Percudani M, Barbui C, Fortino I et al (2005) Antidepressant drug prescribing among elderly subjects: a population-based study. Int J Geriatr Psychiatry 20:113-118
32. Corrao G, Cesana G, Merlino L (2008) Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy. Biomedical Statisticsand Clinical Epidemiology 2:117-125
33. Mirandola M, Andretta M, Corbari L, et al (2006) Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999- 2002. Pharmacoepidemiol Drug Saf 15(6):412-420
34. WHO Collaborating Centre for Drug Statistic Methodology (2003) Guidelines for ATC classification and DDD assignment. WHO, Oslo
35. Eurostat (2007) European regional and urban statistics reference guide. European Commission, Luxemburg
36. Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
37. Marubini E, Valsecchi MG (1995) Analysing survival data from clinical trials and observational studies. Wiley, Chichester
38. Dieterich M, Irving CB, Park B et al (2010) Intensive case management for severe mental illness. Cochrane Database Syst Rev CD007906
39. Byrne MK, Deane FP (2011) Enhancing patient adherence: outcomes of medication alliance training on therapeutic alliance, insight, adherence, and psychopathology with mental health patients. Int J Ment Health Nurs 20:284-295
40. Nose M, Barbui C, Gray R et al (2003) Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 183:197-206
41. Nose M, Barbui C, Tansella M (2003) How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychol Med 33:1149-1160
42. Jones G (2003) Prescribing and taking medicines. BMJ 327:819
43. Reid S, Barbui C (2010) Long term treatment of depression with selective serotonin reuptake inhibitors and newer antidepressants. BMJ 340:c1468